BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31170851)

  • 1. Biotransformation and bioactivation reactions - 2018 literature highlights.
    Khojasteh SC; Bumpus NN; Driscoll JP; Miller GP; Mitra K; Rietjens IMCM; Zhang D
    Drug Metab Rev; 2019 May; 51(2):121-161. PubMed ID: 31170851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel advances in biotransformation and bioactivation research-2019 year in review
    Khojasteh SC; Driscoll JP; Jackson KD; Miller GP; Mitra K; Rietjens IMCM; Zhang D
    Drug Metab Rev; 2020 Aug; 52(3):333-365. PubMed ID: 32645275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation and bioactivation reactions - 2017 literature highlights
    Khojasteh SC; Miller GP; Mitra K; Rietjens IMCM
    Drug Metab Rev; 2018 Aug; 50(3):221-255. PubMed ID: 29954222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation and bioactivation reactions - 2016 literature highlights.
    Khojasteh SC; Rietjens IMCM; Dalvie D; Miller G
    Drug Metab Rev; 2017 Aug; 49(3):285-317. PubMed ID: 28468514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactivation and reactivity research advances - 2021 year in review.
    Jackson KD; Argikar UA; Cho S; Crouch RD; Driscoll JP; Heck CJS; King L; Maw HH; Miller GP; Seneviratne HK; Wang S; Wei C; Zhang D; Khojasteh SC
    Drug Metab Rev; 2022 Aug; 54(3):246-281. PubMed ID: 35876116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel advances in biotransformation and bioactivation research - 2020 year in review.
    Khojasteh SC; Argikar UA; Driscoll JP; Heck CJS; King L; Jackson KD; Jian W; Kalgutkar AS; Miller GP; Kramlinger V; Rietjens IMCM; Teitelbaum AM; Wang K; Wei C
    Drug Metab Rev; 2021 Aug; 53(3):384-433. PubMed ID: 33910427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotransformation research advances - 2022 year in review.
    Khojasteh SC; Argikar UA; Cheruzel L; Cho S; Crouch RD; Dhaware D; Heck CJS; Johnson KM; Kalgutkar AS; King L; Liu J; Ma B; Maw H; Miller GP; Seneviratne HK; Takahashi RH; Wang S; Wei C; Jackson KD
    Drug Metab Rev; 2023 Nov; 55(4):301-342. PubMed ID: 37737116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in drug transporter sciences: highlights from the year 2020.
    Chothe PP; Nakakariya M; Rotter CJ; Sandoval P; Tohyama K
    Drug Metab Rev; 2021 Aug; 53(3):321-349. PubMed ID: 34346798
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism of New Drug Modalities Research Advances - 2023 year in review.
    Ma B; Argikar U; Cheruzel L; Cho S; Hauri S; Johnson K; Liu J; Schadt S; Wang S; Khojasteh SC
    Drug Metab Rev; 2024 Jun; ():1-46. PubMed ID: 38895934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactivation and reactivity research advances - 2022 year in review‡.
    Wang S; Argikar UA; Cheruzel L; Cho S; Crouch RD; Dhaware D; Heck CJS; Johnson KM; Kalgutkar AS; King L; Liu J; Ma B; Maw H; Miller GP; Seneviratne HK; Takahashi RH; Wei C; Khojasteh SC
    Drug Metab Rev; 2023 Nov; 55(4):267-300. PubMed ID: 37608698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel insights in drug transporter sciences: the year 2021 in review.
    Chothe PP; Mitra P; Nakakariya M; Ramsden D; Rotter CJ; Sandoval P; Tohyama K
    Drug Metab Rev; 2022 Aug; 54(3):299-317. PubMed ID: 35762758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Future of Biotransformation Science in the Pharmaceutical Industry.
    Kramlinger VM; Dalvie D; Heck CJS; Kalgutkar AS; O'Neill J; Su D; Teitelbaum AM; Totah RA
    Drug Metab Dispos; 2022 Mar; 50(3):258-267. PubMed ID: 34921097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation and bioactivation reactions of alicyclic amines in drug molecules.
    Bolleddula J; DeMent K; Driscoll JP; Worboys P; Brassil PJ; Bourdet DL
    Drug Metab Rev; 2014 Aug; 46(3):379-419. PubMed ID: 24909234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity.
    Park BK; Laverty H; Srivastava A; Antoine DJ; Naisbitt D; Williams DP
    Chem Biol Interact; 2011 Jun; 192(1-2):30-6. PubMed ID: 20846520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro screening techniques for reactive metabolites for minimizing bioactivation potential in drug discovery.
    Prakash C; Sharma R; Gleave M; Nedderman A
    Curr Drug Metab; 2008 Nov; 9(9):952-64. PubMed ID: 18991592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-cytochrome P450-mediated bioactivation and its toxicological relevance.
    Gan J; Ma S; Zhang D
    Drug Metab Rev; 2016 Nov; 48(4):473-501. PubMed ID: 27533622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highlights from the 2014 Applied Pharmaceutical Analysis conference.
    Spriggs FP; Crisino R
    Bioanalysis; 2015; 7(1):9-13. PubMed ID: 25558931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biotransformation novel advances - 2021 year in review.
    Khojasteh SC; Argikar UA; Cho S; Crouch R; Heck CJS; Johnson KM; Kalgutkar AS; King L; Maw HH; Seneviratne HK; Wang S; Wei C; Zhang D; Jackson KD
    Drug Metab Rev; 2022 Aug; 54(3):207-245. PubMed ID: 35815654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.